Xeomin (Merz Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the Xeomin drug offered from Merz Pharmaceuticals, LLC. This Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Merz Pharmaceuticals, LLC
NON-PROPRIETARY NAME: incobotulinumtoxinA
SUBSTANCE NAME: BOTULINUM TOXIN TYPE A
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2010-09-01
END MARKETING DATE: 0000-00-00


Xeomin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXeomin from Merz Pharmaceuticals, LLC
LABELER NAME: Merz Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 50([USP’U]/1)
START MARKETING DATE: 2010-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0259-1605_aa2bf141-9016-41ab-8564-bfa48b27dcb0
PRODUCT NDC: 0259-1605
APPLICATION NUMBER: BLA125360

Other BOTULINUM TOXIN TYPE A Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.BOTOX
Galderma Laboratories, L.P.Dysport
Ipsen Biopharmaceuticals, Inc.Dysport
Merz North America, Inc.Xeomin
Merz Pharmaceuticals, LLCXeomin